Reimagining the Language and Translation Space for Patients
Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening.
Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening.
The preliminary results from three clinical trials administering gene therapy to address deafness from otoferlin mutations mark inspiring and incredible progress in hearing healthcare.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.